| |
|
With your continued support and participation, BIO-Europe has grown into the premier industry event for getting deals started. The 14th annual BIO-Europe established new standards in partnering productivity with more than 2,400 international biotech and pharma leaders engaging in an astounding 10,250 one-to-one partnering meetings. |
|
| |
|
| |
| |
|
| We look forward to seeing you next year in Milan & Vienna for what are already shaping up to be highly productive partnering events. |
| |
| |
| |
| BIO-Europe is where partnerships get started.
As the largest, most productive stand-alone partnering conference
for the life sciences, BIO-Europe annually attracts the international “who’s
who” from
biotech, pharma and finance for three days of high level networking.
BIO-Europe’s world-class workshops, panels and active exhibition
along with thousands of pre-scheduled one-to-one meetings make
this event an unrivalled forum for companies across the biotech
value-chain to meet and do business. Attend BIO-Europe and experience
how you can have more partnering meetings in the three days of
the conference than in the rest of the year. |
| |
| |
| BIO-Europe brings together life science industry
leaders and deal-makers, including CEOs, business development executives,
venture capitalists, investment bankers and other experts. The
conference attracts biotech companies, large and mid-sized pharma
and features some of the world’s hottest emerging
companies with the most exciting development programs, providing
delegates with an unparalleled opportunity to create new value
generating partnerships. If meeting with as many of the deal-makers
from biotech and pharma as possible is part of your growth strategy,
then there is no better value for money event in the calendar than
BIO-Europe. |
| |
| |
| |
|
 |
|
State-of-the-art
partnering software that enables participants
to select the most suitable potential partners. The
system - industry-specific, web based and interactive
- is uniquely suited for the needs of biotech and pharma
companies. |
|
| |
|
| |
|
|
|
 |
|
Selected biotechnology, mid-sized &
big pharmaceutical companies present their
products/technologies and corporate missions in 15 minute
presentations. |
|
| |
|
| |
|
|
|
 |
|
High level faculty
on panels and workshops,
in which industry experts provide updated analyses and
share their experience with the audience. |
|
| |
|
| |
|
|
|
 |
|
An international exhibition of
major bio-industry leaders who showcase their products,
services and technologies. |
|
| |
|
|
| |
| |
| |
| |
|
| |
•
10,250 one-to-one meetings (18% up from
2007)
•
2,400 delegates
•
Over 1,350 companies
•
45 countries represented |
| |
| |
|
| |
• 10 big Pharma presentations
• 16 mid-sized harma presentations
• 160 Biotech company presentations
|
| |
| |
|
| |
• 83 international
exhibitors |
| |
| |
|
| |
|
|
|
|
| |
 |
|
| |
|
| |
|
|
| |
|
| |
BIO-Europe Spring 2009
March 16-18, 2009
Milan, Italy
www.ebdgroup.com/bes
EuroMedtech 2009
June, 3-4, 2009
Duesseldorf, Germany
www.ebdgroup.com/emt
BioPharm America 2009
September 16-18, 2009
San Francisco, CA, USA
www.ebdgroup.com/bpa
|
| |
|
 |
email update@ebdgroup.com to
receive news on this and other EBD Group
conferences. |
| |
|
| |
| |
| NOTE: EBD
Group is taking substantial steps to
produce environmentally-friendly conferences.To
reduce paper waste, conference materials
will only be available through the internet.
By providing electronic materials, conference
attendees will have the option to download
and/or print only the information that
is relevant to them, thereby reducing
waste. |
| |
|
|
|
|
|
|
